Doc Pharma S.A.
FDA import alert and refusal historyKoropi, GreeceFEI 3027544665
Recorded by FDA as DOC PHARMA S.A.
As of October 25, 2026, Doc Pharma S.A. is not on any FDA import alert in SupplierRadar's records; FDA refused 15 of its shipment lines on October 12, 2023, most often for not identified as a dietary supplement (DIETARYLBL).
Data from FDA public records, last checked . Request a correction
Current status
- Import alerts
- Not listed
- Last import refusal
- Vitamin, mineral, proteins and unconventional dietary specialities for humans and animals, n.e.c. · DIETARYLBL
- Last warning letter
- None found
- Last inspection
- None on record
Every FDA record for Doc Pharma S.A.
15 records, newest first. Each line links to the FDA page it came from.
2023
- Import refusalSource
Refused, 15 lines in one entry: Vitamin, mineral, proteins and unconventional dietary specialities for humans and animals, n.e.c.; Aloe (herbal and botanical (not teas) ii (continued)) and 7 moreDIETARYLBLDIETARYINGDIETARYEntry 8SP-0107541-6Show 15 linesHide lines
- Refused, Vitamin, mineral, proteins and unconventional dietary specialities for humans and animals, n.e.c.DIETARYLBLDIETARYINGEntry 8SP-0107541-6Source
- Refused, Vitamin, mineral, proteins and unconventional dietary specialities for humans and animals, n.e.c.DIETARYLBLEntry 8SP-0107541-6Source
- Refused, Vitamin, mineral, proteins and unconventional dietary specialities for humans and animals, n.e.c.DIETARYLBLEntry 8SP-0107541-6Source
- Refused, Aloe (herbal and botanical (not teas) ii (continued))DIETARYEntry 8SP-0107541-6Source
- Refused, Herbals & botanicals (not teas), n.e.c.DIETARYLBLEntry 8SP-0107541-6Source
- Refused, Omega-3 (fats and lipid substances)DIETARYLBLEntry 8SP-0107541-6Source
- Refused, Vitamin, mineral, proteins and unconventional dietary specialities for humans and animals, n.e.c.DIETARYLBLEntry 8SP-0107541-6Source
- Refused, Mineral n.e.c.DIETARYLBLEntry 8SP-0107541-6Source
- Refused, Zinc (mineral)DIETARYLBLEntry 8SP-0107541-6Source
- Refused, Magnesium (mineral)DIETARYLBLDIETARYINGEntry 8SP-0107541-6Source
- Refused, Zinc (mineral)DIETARYLBLEntry 8SP-0107541-6Source
- Refused, Vitamin, n.e.c.DIETARYLBLEntry 8SP-0107541-6Source
- Refused, Ashwagandha (herbal & botanicals, not teas)DIETARYLBLEntry 8SP-0107541-6Source
- Refused, Vitamin, n.e.c.DIETARYLBLEntry 8SP-0107541-6Source
- Refused, Vitamin, n.e.c.DIETARYEntry 8SP-0107541-6Source
Refusal charges, in plain English
- DIETARYLBL13 refused lines
Not identified as a dietary supplement
The label appeared not to identify the product with the term "dietary supplement" (which may be modified with the name of an ingredient).
- DIETARY2 refused lines
DIETARY
- DIETARYING2 refused lines
Dietary ingredients not listed
The dietary supplement label appeared not to list each dietary ingredient and its quantity, or the total quantity of a proprietary blend.
Questions about Doc Pharma S.A.
- Is Doc Pharma S.A. on an FDA import alert?
- No listing for Doc Pharma S.A. appears in the FDA import alerts SupplierRadar checked on October 25, 2026. Country-wide alerts may still apply to its products; see the Greece page.
- Has FDA refused shipments from Doc Pharma S.A.?
- Yes. FDA refused 15 shipment lines from Doc Pharma S.A. on October 12, 2023. The most recent, on October 12, 2023, was vitamin, mineral, proteins and unconventional dietary specialities for humans and animals, n.e.c., charged as DIETARYLBL (not identified as a dietary supplement).
- Why did FDA refuse Doc Pharma S.A.'s shipments?
- The most frequent charges are DIETARYLBL (not identified as a dietary supplement, 13 lines) and DIETARY (dietary, 2 lines).
- What is Doc Pharma S.A.'s FEI number?
- Doc Pharma S.A.'s FDA Establishment Identifier (FEI) is 3027544665.
Buying from Doc Pharma S.A.?
Watch it and get the FDA record the day it changes. Free for one supplier.
SupplierRadar is not affiliated with the U.S. Food and Drug Administration. Data comes from public FDA records and may contain errors. This is not legal advice; importers remain responsible for their supplier evaluations.